MR diffusion tensor and perfusion-weighted imaging in preoperative grading of supratentorial nonenhancing gliomas

Neuro-Oncology

Volumn 13, Issue 4, 2011, Pages 447-455

  Liu, Xiang ^a   Tian, Wei ^a   Kolar, Balasubramanya ^a   Yeaney, Gabrielle A ^a   Qiu, Xing ^a   Johnson, Mahlon D ^a   Ekholm, Sven ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Brain; Diffusion tensor imaging; Nonenhancing glioma; Perfusion weighted imaging

Indexed keywords

ADULT; ARTICLE; ASTROCYTOMA; CANCER GRADING; DIFFUSION TENSOR IMAGING; GLIOBLASTOMA; GLIOMA; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; OLIGODENDROGLIOMA; PERFUSION WEIGHTED IMAGING; PREOPERATIVE EVALUATION; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY;

ADULT; BRAIN NEOPLASMS; CONTRAST MEDIA; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; GLIOMA; HUMANS; MALE; PERFUSION IMAGING; PREOPERATIVE CARE; PROGNOSIS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SUPRATENTORIAL NEOPLASMS;

EID: 79955758550     PISSN: 15228517     EISSN: 15235866     Source Type: Journal    
DOI: 10.1093/neuonc/noq197     Document Type: Article

References (37)

1. Ginsberg LE, Fuller GN, Hashmi M, Leeds NE, Schomer DF. The significance of lack of MR contrast enhancement of supratentorial brain tumors in adults: Histopathological evaluation of a series. Surg Neurol. 1998; 49:436-440. (Pubitemid 28153024)
2. Fan GG, Deng QL, Wu ZH, Guo QY. Usefulness of diffusion/perfusion- weighted MRI in patients with non-enhancing supratentorial brain gliomas: A valuable tool to predict tumour grading? Br J Radiol. 2006; 79:652-658. (Pubitemid 44283154)
3. White ML, Zhang Y, Kirby P, Ryken TC. Can tumor contrast enhancement be used as a criterion for differentiating tumor grades of oligodendrogliomas? AJNR Am J Neuroradiol. 2005; 26:784-790. (Pubitemid 43079768)
4. Maia AC, Jr, Malheiros SM, da Rocha AJ, et al. MR cerebral blood volume maps correlated with vascular endothelial growth factor expression and tumor grade in nonenhancing gliomas. AJNR Am J Neuroradiol. 2005; 26:777-783. (Pubitemid 43079767)
5. Mihara F, Numaguchi Y, Rothman M, Kristt D, Fiandaca M, Swallow L. Non-enhancing supratentorial malignant astrocytomas: MR features and possible mechanisms. Radiat Med. 1995; 13:11-17.
6. Scott JN, Brasher PM, Sevick RJ, Rewcastle NB, Forsyth PA. How often are nonenhancing supratentorial gliomas malignant? A population study. Neurology. 2002; 59:947-949.
7. Barker FG, 2nd, Chang SM, Huhn SL, et al. Age and the risk of anaplasia in magnetic resonance-nonenhancing supratentorial cerebral tumors. Cancer. 1997; 80:936-941 (Pubitemid 27360923)
8. Batra A, Tripathi RP, Singh AK. Perfusion magnetic resonance imaging and magnetic resonance spectroscopy of cerebral gliomas showing imperceptible contrast enhancement on conventional magnetic resonance imaging. Australas Radiol. 2004; 48:324-332 (Pubitemid 39421075)
9. Lev MH, Ozsunar Y, Henson JW, et al. Glial tumor grading and outcome prediction using dynamic spin-echo MR susceptibility mapping compared with conventional contrast-enhanced MR: Confounding effect of elevated rCBV of oligodendrogliomas. AJNR Am J Neuroradiol. 2004; 25:214-221 (Pubitemid 38235298)
10. Law M, Oh S, Babb JS, et al. Low-grade gliomas: Dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging-prediction of patient clinical response. Radiology. 2006; 238:658-667. (Pubitemid 43134379)
11. Law M, Yang S, Wang H, et al. Glioma grading: Sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging. AJNR Am J Neuroradiol. 2003; 24:1989-1998. (Pubitemid 37444849)
12. Law M, Young RJ, Babb JS, et al. Gliomas: Predicting time to progression or survival with cerebral blood volume measurements at dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging. Radiology. 2008; 247:490-498.
13. Cha S, Knopp EA, Johnson G, Wetzel SG, Litt AW, Zagzag D. ntracranial mass lesions: Dynamic contrast-enhanced susceptibility-weighted echo-planar perfusion MR imaging. Radiology. 2002; 223:11-29. (Pubitemid 34258186)
14. Lee EJ, Lee SK, Agid R, Bae JM, Keller A, Terbrugge K. Preoperative grading of presumptive low-grade astrocytomas on MR imaging: Diagnostic value of minimum apparent diffusion coefficient. AJNR Am J Neuroradiol. 2008; 29:1872-1877.
15. Higano S, Yun X, Kumabe T, et al. Malignant astrocytic tumors: Clinical Importance of apparent diffusion coefficient in prediction of grade and prognosis. Radiology. 2006; 241:839-846. (Pubitemid 46190551)
16. Kikuchi T, Kumabe T, Higano S, Watanabe M, Tominaga T. Minimum apparent diffusion coefficient for the differential diagnosis of ganglioglioma. Neurol Res. 2009; 31:1102-1107.
17. Murakami R, Hirai T, Sugahara T, et al. Grading astrocytic tumors by using apparent diffusion coefficient parameters: superiority of a one-versus two-parameter pilot method. Radiology. 2009; 251:838-845.
18. Murakami R, Sugahara T, Nakamura H, et al. Malignant supratentorial astrocytoma treated with postoperative radiation therapy: Prognostic value of pretreatment quantitative diffusion-weighted MR imaging. Radiology. 2007; 243:493-499. (Pubitemid 46649706)
19. Goebell E, Paustenbach S, Vaeterlein O, et al. Low-grade and anaplastic gliomas: Differences in architecture evaluated with diffusion-tensor MR Imaging. Radiology. 2006; 239:217-222.
20. Lee HY, Na DG, Song IC, et al. Diffusion-tensor imaging for glioma grading at 3-T magnetic resonance imaging: Analysis of fractional anisotropy and mean diffusivity. J Comput Assist Tomogr. 2008; 32:298-303. (Pubitemid 351489457)
21. Misaki T, Beppu T, Inoue T, Ogasawara K, Ogawa A, Kabasawa H. Use of fractional anisotropy value by diffusion tensor MRI for preoperative diagnosis of astrocytic tumors: Case report. J Neurooncol. 2004; 70:343-348. (Pubitemid 40057963)
22. Inoue T, Ogasawara K, Beppu T, Ogawa A, Kabasawa H. Diffusion tensor imaging for preoperative evaluation of tumor grade in gliomas. Clin Neurol Neurosurg. 2005; 107:174-180.
23. Beppu T, Inoue T, Shibata Y, et al. Fractional anisotropy value by diffusion tensor magnetic resonance imaging as a predictor of cell density and proliferation activity of glioblastomas. Surg Neurol. 2005; 63:56-61 (Pubitemid 40082437)
24. Beppu T, Inoue T, Shibata Y, et al. Measurement of fractional anisotropy using diffusion tensor MRI in supratentorial astrocytic tumors. J Neurooncol. 2003; 63:109-116. (Pubitemid 36705680)
25. Kinoshita M, Hashimoto N, Goto T, et al. Fractional anisotropy and tumor cell density of the tumor core show positive correlation in diffusion tensor magnetic resonance imaging of malignant brain tumors. Neuroimage. 2008; 43:29-35.
26. Stadlbauer A, Ganslandt O, Buslei R, et al. Gliomas: Histopathologic evaluation of changes in directionality and magnitude of water diffusion at diffusion-tensor MR imaging. Radiology. 2006; 240:803-810. (Pubitemid 44267338)
27. Cha S. Dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging in pediatric patients. Neuroimaging Clin N Am. 2006; 16:137-147.
28. Liu X, Ekholm S, Westesson P. MR perfusion imaging and diffusion tensor imaging in the evaluation of high grade and low grade non-enhancing cerebral gliomas. Paper presented at: scientific assembly and program of the 94th annual meeting of Radiological Society of North America, 2008, Chicago. P143.
29. Macdonald DR, Cascino TL, Schold SC, Jr, Cairncross JG. Response criteria for phase II studies of supratentorial malignant glioma. J Clin Oncol. 1990; 8:1277-1280. (Pubitemid 20195640)
30. Venables WN, Ripley BD. Modern Applied Statistics with s, 4th ed. New York: Springer; 2002
31. R Development Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing; 2006.
32. Wang S, Kim S, Chawla S, et al. Differentiation between glioblastomas and solitary brain metastases using diffusion tensor imaging. Neuroimage. 2009; 44:653-660.
33. Wippold FJ, 2nd, Lämmle M, Anatelli F, Lennerz J, Perry A. Neuropathology for the neuroradiologist: Palisades and pseudopalisades. AJNR Am J Neuroradiol. 2006; 27:2037-2041 (Pubitemid 44788624)
34. Toh CH, Castillo M, Wong AM, et al. Differentiation between classic and atypical meningiomas with use of diffusion tensor imaging. AJNR Am J Neuroradiol. 2008; 29:1630-1635.
35. Danchaivijitr N, Waldman AD, Tozer DJ, et al. Low-grade gliomas: Do changes in rCBV measurements at longitudinal perfusion-weighted MR imaging predict malignant transformation? Radiology. 2008; 247:170-178.
36. Xu M, See SJ, Ng WH, et al. Comparison of magnetic resonance spectroscopy and perfusion-weighted imaging in presurgical grading of oligodendroglial tumors. Neurosurgery. 2005; 56:919-926.
37. Cha S, Than T, Crawford F, et al. Differentiation of low-grade oligodendrogliomas from low-grade astrocytomas by using quantitative blood-volume measurements derived from dynamic susceptibility contrast-enhanced MR imaging. AJNR Am J Neuroradiol. 2005; 26:266-273. (Pubitemid 43073303)